Kandesartancileksetil/amlodipin/hidroklorotiazid Adamed 16 mg/5 mg/12,5 mg tvrde kapsule
| Name | Kandesartancileksetil/amlodipin/hidroklorotiazid Adamed 16 mg/5 mg/12,5 mg tvrde kapsule |
|---|---|
| Marketing Authorisation Number | HR-H-738475524 |
| Active Substance | kandesartancileksetil amlodipinbesilat hidroklorotiazid |
| Composition | jedna kapsula sadrži 16 mg kandesartancileksetila, 5 mg amlodipina (u obliku amlodipinbesilata) i 12,5 mg hidroklorotiazida |
| Pharmaceutical Form | Kapsula, tvrda |
| Manufacturer | Adamed Pharma S.A., Pabianice, Poljska |
| Marketing Authorisation Holder | Adamed Pharma S.A., Pienkow, M. Adamkiewicza 6A, Czosnow, Poljska |
| Marketing Authorisation Date | 21.08.2023 |
| MA Period of Validity | 21.08.2028 |
| Classification Number | UP/I-530-09/22-01/68 |
| Registration Number | 381-12-01/171-23-09 |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | C09DX06 |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
